Showing results (111-120 of 3,292) with videos related to
Sort By:
Pageof 330
Rheumatology (Oxford, England)|September 15, 2017
Reviewing the evidence for biosimilars: key insights, lessons learned and future horizonsTill Uhlig, Guro L GollThe Journal of Biological Chemistry|June 25, 1991
Binding of calpain fragments to calpastatinT Nishimura, D E GollPraxis Der Kinderpsychologie Und Kinderpsychiatrie|September 6, 2018
[Multifamilygroups as a Psychosocial and Contextoriented Intervention for Somatic Illness and Disability]Andrea Goll-Kopka, Anja BornHealth Affairs (Project Hope)|September 18, 2001
Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPSF R LichtenbergForum for Health Economics & Policy|August 18, 2019
The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use FilesFrank R LichtenbergHealth Affairs (Project Hope)|August 9, 2011
Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-beingFrank R LichtenbergHealth Economics|July 18, 2008
Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003Frank R LichtenbergJournal of Toxicology and Environmental Health|November 1, 1975
Schistosomiasis as a worldwide problem: pathologyF von LichtenbergExpert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series dataFrank R LichtenbergInternational Journal of Health Economics and Management|November 24, 2016
The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000-2011Frank R LichtenbergPageof 330